vs

Side-by-side financial comparison of BayCom Corp (BCML) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $25.9M, roughly 1.5× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs 24.7%, a 1.8% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

BCML vs CDXS — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.5× larger
CDXS
$38.9M
$25.9M
BCML
Growing faster (revenue YoY)
CDXS
CDXS
+71.9% gap
CDXS
81.3%
9.4%
BCML
Higher net margin
BCML
BCML
1.8% more per $
BCML
26.5%
24.7%
CDXS
More free cash flow
BCML
BCML
$10.5M more FCF
BCML
$30.1M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
CDXS
CDXS
Revenue
$25.9M
$38.9M
Net Profit
$6.9M
$9.6M
Gross Margin
94.8%
Operating Margin
36.6%
27.1%
Net Margin
26.5%
24.7%
Revenue YoY
9.4%
81.3%
Net Profit YoY
12.1%
192.5%
EPS (diluted)
$0.63
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
CDXS
CDXS
Q4 25
$25.9M
$38.9M
Q3 25
$25.7M
$8.6M
Q2 25
$24.7M
$15.3M
Q1 25
$24.3M
$7.5M
Q4 24
$23.7M
$21.5M
Q3 24
$25.6M
$12.8M
Q2 24
$23.8M
$8.0M
Q1 24
$24.5M
$17.1M
Net Profit
BCML
BCML
CDXS
CDXS
Q4 25
$6.9M
$9.6M
Q3 25
$5.0M
$-19.6M
Q2 25
$6.4M
$-13.3M
Q1 25
$5.7M
$-20.7M
Q4 24
$6.1M
$-10.4M
Q3 24
$6.0M
$-20.6M
Q2 24
$5.6M
$-22.8M
Q1 24
$5.9M
$-11.5M
Gross Margin
BCML
BCML
CDXS
CDXS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
BCML
BCML
CDXS
CDXS
Q4 25
36.6%
27.1%
Q3 25
26.3%
-220.3%
Q2 25
35.3%
-83.9%
Q1 25
31.6%
-271.6%
Q4 24
34.2%
-34.2%
Q3 24
32.4%
-129.0%
Q2 24
31.9%
-284.9%
Q1 24
33.3%
-69.6%
Net Margin
BCML
BCML
CDXS
CDXS
Q4 25
26.5%
24.7%
Q3 25
19.5%
-228.1%
Q2 25
25.8%
-86.6%
Q1 25
23.4%
-274.3%
Q4 24
25.9%
-48.4%
Q3 24
23.5%
-160.8%
Q2 24
23.6%
-285.2%
Q1 24
24.0%
-67.4%
EPS (diluted)
BCML
BCML
CDXS
CDXS
Q4 25
$0.63
$0.13
Q3 25
$0.46
$-0.22
Q2 25
$0.58
$-0.16
Q1 25
$0.51
$-0.25
Q4 24
$0.55
$-0.12
Q3 24
$0.54
$-0.29
Q2 24
$0.50
$-0.32
Q1 24
$0.51
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$338.6M
$50.5M
Total Assets
$2.6B
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
CDXS
CDXS
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
BCML
BCML
CDXS
CDXS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
BCML
BCML
CDXS
CDXS
Q4 25
$338.6M
$50.5M
Q3 25
$334.3M
$38.5M
Q2 25
$330.6M
$55.6M
Q1 25
$329.3M
$49.6M
Q4 24
$324.4M
$66.9M
Q3 24
$321.7M
$73.4M
Q2 24
$315.3M
$61.4M
Q1 24
$314.2M
$79.3M
Total Assets
BCML
BCML
CDXS
CDXS
Q4 25
$2.6B
$147.8M
Q3 25
$2.6B
$124.0M
Q2 25
$2.6B
$138.2M
Q1 25
$2.6B
$128.9M
Q4 24
$2.7B
$149.0M
Q3 24
$2.6B
$148.2M
Q2 24
$2.6B
$132.0M
Q1 24
$2.6B
$149.6M
Debt / Equity
BCML
BCML
CDXS
CDXS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
CDXS
CDXS
Operating Cash FlowLast quarter
$31.8M
$20.1M
Free Cash FlowOCF − Capex
$30.1M
$19.6M
FCF MarginFCF / Revenue
116.2%
50.3%
Capex IntensityCapex / Revenue
6.7%
1.3%
Cash ConversionOCF / Net Profit
4.64×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
CDXS
CDXS
Q4 25
$31.8M
$20.1M
Q3 25
$7.3M
$-7.7M
Q2 25
$6.4M
$-18.0M
Q1 25
$9.3M
$-13.8M
Q4 24
$30.4M
$-16.5M
Q3 24
$9.6M
$-13.0M
Q2 24
$7.7M
$-12.2M
Q1 24
$5.1M
$-7.8M
Free Cash Flow
BCML
BCML
CDXS
CDXS
Q4 25
$30.1M
$19.6M
Q3 25
$6.2M
$-7.9M
Q2 25
$5.6M
$-20.5M
Q1 25
$9.1M
$-15.1M
Q4 24
$28.7M
$-18.2M
Q3 24
$9.4M
$-14.0M
Q2 24
$7.4M
$-12.6M
Q1 24
$3.9M
$-8.9M
FCF Margin
BCML
BCML
CDXS
CDXS
Q4 25
116.2%
50.3%
Q3 25
24.3%
-91.7%
Q2 25
22.8%
-133.6%
Q1 25
37.6%
-199.6%
Q4 24
121.1%
-85.0%
Q3 24
36.6%
-109.0%
Q2 24
31.2%
-157.5%
Q1 24
16.1%
-52.2%
Capex Intensity
BCML
BCML
CDXS
CDXS
Q4 25
6.7%
1.3%
Q3 25
4.3%
2.1%
Q2 25
3.0%
16.4%
Q1 25
0.6%
16.7%
Q4 24
7.2%
8.3%
Q3 24
1.0%
7.8%
Q2 24
1.0%
5.0%
Q1 24
4.7%
6.6%
Cash Conversion
BCML
BCML
CDXS
CDXS
Q4 25
4.64×
2.09×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons